Inferra AI / Company / NGVT
Ingevity Corp
NGVT · Materials
Last earnings Jul 29, 2026
Key results
EPSquarter
$1.39
earnings per share of $1.39 was up 38% Adjusted EBITDA of $110.0 million increased 9% and adjusted EBITDA margin improved to 30.1% primarily due to the successful execution of repositioning actions in Performance Chemicals
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Net revenuequarter
$365.1 million
Net sales of $365.1 million declined 7% primarily due to lower sales in the Performance Chemicals segment.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Adjusted earnings increased 39% to $51.1 million and diluted adjusted earnings per share (EPS) increased 38% to $1.39.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Free cash flowquarter
$79.0 million
Liquidity Other Operating cash flow was $79.0 million with free cash flow of $66.8 million, reflecting improved profitability, lower repositioning spend in Performance Chemicals and disciplined capital spend.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
AI analysis
Q2 2025 · reported Aug 4, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
The quarter in charts
Guidance ladder — revenue
Delivered vs the company's guided range
EX-99 · Aug 4, 2025 Guide as stated by the company; range and midpoint computed from the stated figure.
Headline figures
| Metric | Q2 2025 | Prior qtr | Year ago |
|---|---|---|---|
| EPS | $1.39 | — | — |
| Net revenue | $365.1 million | — | — |
| Free cash flow | $79.0 million | — | — |
Guidance · company-stated
Direction: Raised
“Full Year 2025 Guidance Due to solid first half results and improved North America auto production forecasts, the Company is raising the low-end of adjusted EBITDA guidance with updated guidance of between $390 million and $415 million and maintaining sales guidance between $1.25 billion and $1.40 billion.”
Classified from the release's primary full-year outlook statement.
Cash flow & capex
Capital allocation
There were no share repurchases for the quarter and $353.4 million remains available under the current $500 million Board authorization.
We have excluded the following items from segment EBITDA interest expense associated with corporate debt facilities, interest income, income taxes, depreciation, amortization, restructuring and other income (charges), net, inventory lower of cost or market charges associated with restructuring actions, goodwill impairment charges, acquisition and other-related income (costs), litigation verdict charges, gain (loss) on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment income (charges), net.
What changed vs last quarter
- Guide midpoint vs latest-quarter revenue +6.8% computed from stated figures
Event summary
Refer to the section entitled Use of non-GAAP financial measures within this release
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Raised
Revenue: “Full Year 2025 Guidance Due to solid first half results and improved North America auto production forecasts, the Company is raising the low-end of adjusted EBITDA guidance with updated guidance of between $390 million and $415 million and maintaining sales guidance between $1.25 billion and $1.40 billion.”
Revenue — Raised (“raising”)
“Full Year 2025 Guidance Due to solid first half results and improved North America auto production forecasts, the Company is raising the low-end of adjusted EBITDA guidance with updated guidance of between $390 million and $415 million and maintaining sales guidance between $1.25 billion and $1.40 billion.”
Classified from the release's primary full-year outlook statement.
Capital allocation
There were no share repurchases for the quarter and $353.4 million remains available under the current $500 million Board authorization.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
We have excluded the following items from segment EBITDA interest expense associated with corporate debt facilities, interest income, income taxes, depreciation, amortization, restructuring and other income (charges), net, inventory lower of cost or market charges associated with restructuring actions, goodwill impairment charges, acquisition and other-related income (costs), litigation verdict charges, gain (loss) on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment income (charges), net.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Ingevity uses the following non-GAAP measures Adjusted earnings (loss) is defined as net income (loss) plus restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, pension and postretirement settlement and curtailment (income) charges, loss on CTO resales, CTO supply contract termination charges, (gain) loss on strategic investments, debt refinancing fees, litigation verdict charges, proxy contest charges, and the income tax expense (benefit) on those items, less the provision (benefit) from certain discrete tax items.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Free Cash Flow is defined as the sum of net cash provided by (used in) the following items operating activities less capital expenditures.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Net Debt is defined as the sum of notes payable, short-term debt, current maturities of long-term debt and long-term debt including finance lease obligations less the sum of cash and cash equivalents, restricted cash associated with our new market tax credit financing arrangement, and restricted investment associated with certain finance lease obligations, excluding the allowance for credit losses on held-to-maturity debt securities held within the restricted investment.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Net Debt Ratio is defined as Net Debt divided by the last twelve months Adjusted EBITDA, inclusive of acquisition-related pro forma adjustments.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Strategy & priorities
We are also advancing our portfolio evaluation with a focus on retaining and investing in businesses that leverage our core competencies and also allow us to continue driving sustainable growth and delivering best-in-class EBITDA margins.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
We have excluded the following items from segment EBITDA interest expense associated with corporate debt facilities, interest income, income taxes, depreciation, amortization, restructuring and other income (charges), net, inventory lower of cost or market charges associated with restructuring actions, goodwill impairment charges, acquisition and other-related income (costs), litigation verdict charges, gain (loss) on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment income (charges), net.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Three Months Ended June 30, Six Months Ended June 30, In millions 2025 2024 2025 2024 Performance Materials $ $ (0.1) $ $ (0.1) Performance Chemicals 4.8 Advanced Polymer Technologies 2.5 2.5 (Gain) loss on strategic investments $ 2.5 $ (0.1) $ 2.5 $ 4.7 (9) Charges represent legal and other professional service fees as well as incremental proxy solicitation costs related to a proxy contest.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Ingevity uses the following non-GAAP measures Adjusted earnings (loss) is defined as net income (loss) plus restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, pension and postretirement settlement and curtailment (income) charges, loss on CTO resales, CTO supply contract termination charges, (gain) loss on strategic investments, debt refinancing fees, litigation verdict charges, proxy contest charges, and the income tax expense (benefit) on those items, less the provision (benefit) from certain discrete tax items.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Adjusted EBITDA is defined as net income (loss) plus interest expense, net, provision (benefit) for income taxes, depreciation, amortization, restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, litigation verdict charges, (gain) loss on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment (income) charges, net.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Risks & headwinds
This impairment was recorded as a result of an impact assessment of heightened global trade uncertainty due to tariff announcements during the quarter, which prompted reevaluation of prior assumptions regarding the pace and strength of industrial demand recovery in key markets.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Performance Materials Performance Materials sales were down 2% to $153.9 million as higher sales in North America partially offset lower sales in Asia and Europe, attributable primarily to tariff uncertainty.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Advanced Polymer Technologies Sales in Advanced Polymer Technologies were down $4.6 million, or 10%, to $43.3 million primarily as a result of softening customer demand, which intensified late in the quarter due to indirect impacts from tariffs, particularly in Europe.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Segment EBITDA decreased from $9.8 million to $0.9 million largely due to the planned extended outage in Q2 to install new boilers noted last quarter, and lower volumes attributed to slow industrial demand and tariff-related pressures.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
We have excluded the following items from segment EBITDA interest expense associated with corporate debt facilities, interest income, income taxes, depreciation, amortization, restructuring and other income (charges), net, inventory lower of cost or market charges associated with restructuring actions, goodwill impairment charges, acquisition and other-related income (costs), litigation verdict charges, gain (loss) on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, and pension and postretirement settlement and curtailment income (charges), net.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Ingevity uses the following non-GAAP measures Adjusted earnings (loss) is defined as net income (loss) plus restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, pension and postretirement settlement and curtailment (income) charges, loss on CTO resales, CTO supply contract termination charges, (gain) loss on strategic investments, debt refinancing fees, litigation verdict charges, proxy contest charges, and the income tax expense (benefit) on those items, less the provision (benefit) from certain discrete tax items.
SEC original ↗Ingevity Corp — Earnings release (8-K exhibit)EX-99Aug 4, 2025
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
30 documents- Q2 2026
- 10-QNGVT
Jul 30, 2026
- 8-KNGVT
Jul 29, 2026
- Q1 2026
- 8-KNGVT
Jun 24, 2026
- 10-QNGVT
May 7, 2026
- 8-KNGVT
May 6, 2026
- 8-KNGVT
May 4, 2026
- 8-KNGVT
Apr 15, 2026
- Q4 2025
- 8-KNGVT
Mar 30, 2026
- 10-KNGVT
Feb 26, 2026
- 8-KNGVT
Feb 25, 2026
- 8-KNGVT
Feb 23, 2026
- 8-KNGVT
Jan 5, 2026
- Q3 2025
- 8-KNGVT
Dec 8, 2025
- 8-KNGVT
Dec 8, 2025
- 8-KNGVT
Dec 1, 2025
- 10-QNGVT
Nov 6, 2025
- 8-KNGVT
Nov 5, 2025
- 8-KNGVT
Oct 23, 2025
- Q2 2025
- 8-KNGVT
Sep 4, 2025
- 10-QNGVT
Aug 5, 2025
- 8-KNGVT
Aug 4, 2025
- 8-KNGVT
Jul 1, 2025
- Q1 2025
- 10-QNGVT
May 6, 2025
- 8-KNGVT
May 5, 2025
- 8-KNGVT
May 1, 2025
- Q4 2024
- 8-KNGVT
Mar 31, 2025
- 8-KNGVT
Mar 10, 2025
- 10-KNGVT
Feb 19, 2025
- 8-KNGVT
Feb 18, 2025
- 8-KNGVT
Jan 16, 2025
Earnings releases
10 documentsPresentations
0 documentsNo presentations for Ingevity Corp are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Ingevity Corp are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.